Biotech Business - January 20, 2026
Affibody carries out fully guaranteed rights issue
The Board of Directors of the company has resolved to carry out a fully guaranteed rights issue of SEK 307 million.
Financing - January 12, 2026
EpiEndo completes a EUR 9 million convertible bond issue
The company has raised EUR 5 million of new funding from new and existing investors via a EUR 9 million convertible bond issuance.
Financing - December 1, 2025
One-carbon Therapeutics raises SEK 153 million
The company has closed an oversubscribed private placement financing round supported by current and new investors and private Swedish family offices.
Financing - November 12, 2025
Authera secures new funding from the Research Council of Norway
Authera has received funding from the Research Council of Norway through the Innovation Project for the Industrial Sector.
Denmark - November 3, 2025
BOOST Pharma adds Sound Bioventures to investor syndicate
Sound Bioventures has joined the company's investor syndicate with a SEK 34 million investment.
Biotech Business - September 30, 2025
Abera Bioscience awarded £70,000 grant
Abera Bioscience has been awarded a grant from BactiVac, the Bacterial Vaccines Network.